Trial Profile
A single-blind phase I study to assess the residual allergenicity of tyrosine adsorbed ragweed pollen allergoid with MPL [monophosphoryl lipid A] using skin prick testing
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Monophosphoryl lipid A (Primary) ; Ragweed allergy immunotherapy (Primary)
- Indications Hypersensitivity
- Focus Pharmacodynamics
- 11 Nov 2005 New trial record.